Santa Cruz Biotechnology provides a broad selection of CRSP34 monoclonal antibodies for research focused on understanding CRSP34 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CRSP34, also known as the cofactor for the transcriptional regulation of steroid hormone receptors, plays a crucial role in gene expression and cellular signaling pathways. Its involvement in the regulation of transcription makes CRSP34 an important target for studies related to cancer, metabolic disorders, and other diseases. Understanding CRSP34 functions can provide insights into the mechanisms of hormone action and the development of therapeutic strategies. Researchers can utilize CRSP34 monoclonal antibodies to investigate protein expression patterns across different tissue types. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of CRSP34 localization and interactions. Multiple format options allow for flexibility in experimental design and optimization. Santa Cruz Biotechnology monoclonal antibodies for CRSP34 research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.